Emerging sex differences in multiple aspects of this lethal brain cancer likely help explain the disease’s more favorable incidence and prognosis in females. And they may point to new targeted therapies.
How Cancer Stem Cells Drive Triple-Negative Breast Cancer
A new study the Department of Cellular and Molecular Medicine identifies a never-before described survival pathway in cancer stem cells (CSCs) that may serve as a potential target for new triple-negative breast cancer (TNBC) treatment therapies.
TLR4: The Key to Cancer Stem Cell Evasion of Immune Suppression?
Through a side-by-side comparison of CSC and non-CSC reactions in specific TLR cultures, Dr. Lathia and his teams found that CSCs in GB have adapted to express a lower level of the innate TLR4. These diminished TLR4 levels allow the CSCs to persist and multiply, repopulating a tumor in a hostile microenvironment.
Researchers Discover How Glioblastoma Stem Cells Evade the Immune System
Cleveland Clinic researchers solve a puzzle that brings them one step closer to finding a treatment for glioblastoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy